Nonradioactive assay helps diagnose heparin reaction - Insights
Rajiv Pruthi, M.B.B.S., explains how Mayo Clinic Laboratories’ serotonin release assay achieves high sensitivity and specificity while avoiding the use of radioactive materials. Serotonin release testing is an important tool in the...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) - Insights
Divyanshu (Div) Dubey, M.B.B.S., describes Mayo Clinic Laboratories' new diagnostic test for CIDP, or chronic inflammatory demyelinating polyneuropathy. The new test detects two antibodies — NF155 and CNTN1 — to enhance diagnosis and guide...
MayoComplete Solid Tumor Panel - Insights
Kevin Halling, M.D., Ph.D., explains how the MayoComplete Solid Tumor panel uses next-generation sequencing to assess 514 clinically significant, cancer-related genes for genetic alterations that offer insight on treatment effectivity.
Urinary ammonium testing - Insights
John Lieske, M.D., discusses Mayo Clinic Laboratories' urinary ammonium testing. A test that takes the guesswork out of determining acid base disorders by giving nephrologists a true understanding of a patient’s true urinary ammonium level.
Melanoma panel provides more tumor information - Insights
In this test specific episode of the "Answers From the Lab" podcast, Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' comprehensive melanoma panel better informs prognosis and treatment.
Comprehensive panel boosts GIST diagnosis sensitivity - Insights
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.
Enhanced detection of genetic mutation to optimize leukemia treatment - Insights
Rong He, M.D., describes how Mayo Clinic Laboratories’ NPM1Q assay detects all known forms of a genetic mutation found in about 30% of people with acute myeloid leukemia, or AML. Identifying the NPM1 mutation is critical for clinical...
Unique pediatric evaluation targets relevant autoimmune/CNS antibodies - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' pediatric autoimmune/CNS testing can better guide the treatment of autoimmune neurological diseases in children. The tailored evaluation covers only biomarkers...
MCL Congenital Heart Disease Genetic Testing Patient Information MC1235298
MCL Congenital Heart Disease Genetic Testing Patient Information Complete print Reset Form Congenital Heart Disease Genetic Testing Patient Information Instructions Accurate interpretation reporting genetic results
Dangerous Goods Training Has Moved - Insights
Update your bookmark! Dangerous Goods can now be found at https://news.mayocliniclabs.com/dangerous-goods-training/
Cytology: A compelling molecular testing approach - Insights
Learn more about how Mayo Clinic Laboratories is advancing the use of cytology specimens for solid tumor next-generation sequencing.
Precision therapeutics - Insights
At Mayo Clinic Laboratories, utilization of precision therapeutics, or pharmacogenomic testing used in conjunction with therapeutic drug monitoring, provides personalized insights to guide and monitor prescription medication use.
It delivers insights that put patients on the right pathway. It drives revenue that can bolster the financial stability of the hospital. It elevates the standards of care in the communities it serves – but only if you recognize your lab’s...
Including comprehensive panels and medication targeted assays, Mayo Clinic Laboratories pharmacogenomic testing focuses on clinically actionable genes and enables the detection of more alleles than other testing.
Dangerous Goods Training - Insights
Self-paced online training and certification for safe collection, handling, packaging, and shipment of specimens.
Clinical Application of Next-Generation Sequencing (NGS) Testing - Insights
October 8, 2017 | Rochester, Minnesota This symposium is designed for any provider who treats patients with hematologic malignancies (e.g., oncologists, hematologists, and physician assistants), pathologists, hematopathologists,...
Patient Satisfaction in the Nursery [Pediatric Phlebotomy] - Insights
This "Pediatric Phlebotomy" presentation addresses the increase in the number of tests available using a blood spot specimen and concerns about bruising, a team was created to investigate causes of bruising and select the best method for...
Battling Borrelia burgdorferi and mayonii: Know the ABCs of Lyme Disease - Insights
In the United States, Lyme disease is caused by "Borrelia burgdorferi" and "Borrelia mayonii" bacteria, carried primarily by "black-legged" or "deer ticks." To learn more about Lyme disease, the Mayo Clinic Department of Laboratory Medicine...
Impact of pre-analytical variables on clinical laboratory testing and patient care - Insights
This "Phlebotomy Webinar" presentation highlights the most common pre-analytical variables encountered in the hospital setting that may compromise blood specimen integrity and lead to specimen recollection.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
Membranous nephropathy assay: PMND1 - Insights
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a...
PIK3CA assay guides treatment of progressing breast cancer - Insights
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...
MCL Viral Susceptibility Lymphoproliferation Hemophagocytic Lymphohistiocytosis Patient Information Complete print Reset Form Viral Susceptibility Lymphoproliferation Hemophagocytic Lymphohistiocytosis Patient Information Instructions...
This “Specialty Testing” webinar will discuss the collaborative effort which led to the discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.
Autoimmune Myelopathy - Insights
This “Specialty Testing” webinar will describe the clinical, radiologic, and serologic characteristics of autoimmune myelopathies and their mimics.
In this month’s “Virtual Lecture,” James Hernandez, M.D., expresses the importance of safety and why it is integral in processing and phlebotomy.
Legal Updates in Phlebotomy - Insights
This "Phlebotomy" webinar will provide an update of litigation trends affecting phlebotomists.
The Role of CSF in Alzheimer's Disease - Insights
This "Specialty Testing" webinar will discuss Cerebrospinal fluid (CSF), which has been used in research on Alzheimer's disease for decades. Only recently, have platforms been developed to standardize measurements across laboratories.
Phlebotomy COVID-19 Process - Insights
This “Phlebotomy Webinar” will focus on the role of the phlebotomist and the changes adapted to provide service safely to COVID positive patients in different service areas (ED, ICU vs General floors).
Using Phlebotomy Quality Metrics to Improve Patient Care - Insights
This “Phlebotomy Webinar" will discuss the what and why of quality metrics and indicators and how to determine which indicators to monitor.
The following resources can be used as a reminder for staff on the order of putting on and taking off, and reuse of PPE.
Mission not impossible: Overcoming challenging pediatric draws - Insights
This “Phlebotomy Webinar” covers real-life challenging scenarios that arise in the clinical setting. Four unique case studies are presented, and suggestions are discussed on how to help and respond in these situations to support the...
Annual screening for latent tuberculosis in healthcare workers: No longer required - Insights
This "Phlebotomy Webinar" presentation will review the methods available to detect latent infection with Mycobacterium tuberculosis, or latent tuberculosis infection (LTBI), including the classic tuberculin skin test and the more recently...
Pathways Case Studies: February 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for February include the following sub-specialties: Anatomic Pathology,...
R. Ross Reichard, M.D., Featured in CAP Today - Insights
R. Ross Reichard, M.D., DLMP Vice Chair of Quality and Associate Chair of Practice, recently contributed to a College of American Pathologists (CAP) article in CAP Today. The article, "How the Laboratory Drives Patient Satisfaction,"...
MCL Inborn Errors Immunity Autoimmunity Autoinflammatory Disease Patient Information Complete print Reset Form Inborn Errors Immunity Autoimmunity Autoinflammatory Disease Patient Information Instructions Accurate interpretation reporting
MCL Infectious Specimen Shipping Guidelines MC1235168
MCL Infectious Specimen Shipping Guidelines Infectious Specimen Shipping Guidelines Shipper Responsibilities test send area considered shipper send specimens
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
Linda Hasadsri, M.D., Ph.D., explains carrier screening at Mayo Clinic Laboratories. Using targeted genotyping, our three focused panels evaluate genes associated with cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to...
Discontinuation of Herpes Simplex Virus (HSV) IgM Testing - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the over utilization of IgM serologic testing for herpes simplex virus and the recommendation by multiple agencies, including the CDC and the Infectious Diseases Society of...
Bile acid malabsorption - Insights
Chronic diarrhea and abdominal pain can be caused by many conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Celiac disease, infectious GI pathogens, and malignancy. When other causes of chronic diarrhea...
Inborn errors of metabolism - Insights
Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can diagnose inborn errors of metabolism.
Find out how our hereditary cancer panels use next-generation sequencing to evaluate dozens of genes associated with cancer risk.
They Did "WHAT?!" Capturing Patient Experience to Increase Patient Satisfaction - Insights
This “Phlebotomy” webinar will discuss how a patient’s “experience” is the entirety of all the interactions that person has had within the health care system. Each member of a health care team plays a role in enhancing patient satisfaction,...
Introduction to Cost of Quality in the Laboratory - Insights
This "Phlebotomy" webinar will provide an introduction to cost of quality. The main components of the presentation will include discussions on the cost of attaining quality and the cost of poor quality.
Pediatric Phlebotomy with Pain Management: Creating an Optimal Experience - Insights
This “Phlebotomy” webinar reviews: Having a medical procedure or a lab draw can be fearful for children. Even if it is their first time or they have had a bad past experience, there are ways to make these procedures easier for children.